Coya Therapeutics (COYA) Common Equity (2021 - 2026)
Coya Therapeutics (COYA) reported Common Equity of $43.28 million for Q2 2026, up 52.9% from $28.31 million a year earlier but down 11.6% from the prior quarter.
Powered by 
Analysis
Coya Therapeutics (COYA) Common Equity (2021 - 2026) Analysis & Trends
At the end of FY2025, Coya Therapeutics posted Common Equity of $43.03 million, up 8.7% from FY2024.
- Common Equity has a four-year compound annual growth rate of 85.4% (FY2021 to FY2025).
- By year, Common Equity came in at $39.58 million in FY2024 (+11.1%), $35.64 million in FY2023, -$8.39 million in FY2022 and $3.64 million in FY2021.
- Five-year quarterly Common Equity spans a low of -$8.39 million in Q4 2022 and a high of $48.97 million in Q1 2026.
- Year over year, Common Equity has now increased in each of the last three quarters, with growth averaging 38.2% over the last eight quarters.
- The high point for year-over-year Common Equity in five years was Q1 2023 (growth of 723.3%); the low point was Q2 2025 (a decline of 19.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $48.97 million (Q1 2026), $43.03 million (Q4 2025) and $27.28 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,166.97 Bn | 1,135.56 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 644.38 Bn | 564.24 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 501.54 Bn | 474.65 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 359.36 Bn | 313.74 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 302.13 Bn | 266.12 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 267.59 Bn | 241.28 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 241.49 Bn | 196.89 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 192.85 Bn | 167.05 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 171.77 Bn | 118.41 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Coya Therapeutics | 96.64 Mn | -72.23 Mn | - | 43.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43.28 Mn |
| Mar 31, 2026 | 48.97 Mn |
| Dec 31, 2025 | 43.03 Mn |
| Sep 30, 2025 | 27.28 Mn |
| Jun 30, 2025 | 28.31 Mn |
| Mar 31, 2025 | 33.37 Mn |
| Dec 31, 2024 | 39.58 Mn |
| Sep 30, 2024 | 32.01 Mn |
| Jun 30, 2024 | 35.26 Mn |
| Mar 31, 2024 | 32.39 Mn |
| Dec 31, 2023 | 35.64 Mn |
| Sep 30, 2023 | 10.09 Mn |
| Jun 30, 2023 | 13.25 Mn |
| Mar 31, 2023 | 16.15 Mn |
| Dec 31, 2022 | -8.39 Mn |
| Sep 30, 2022 | -5.36 Mn |
| Jun 30, 2022 | -1.41 Mn |
| Mar 31, 2022 | 1.96 Mn |
| Dec 31, 2021 | 3.64 Mn |
API Access
Coya Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=COYA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "COYA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=COYA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();